Leading B2B exhibition organizer Informa Markets is once again back with its 15th edition of CPhI and P-MEC India in an evolved hybrid format to be held from 29th November to 1st December 2022 at the India Expo Centre, Greater Noida, Delhi – NCR.

CPhI and P-MEC India create platforms to showcase modern technologies critical in facilitating advancement in India’s pharma machinery, technology, and ingredients industries. Indian pharmaceutical industry is set to grow at a 12% CAGR and reach $ 130 billion by 2030.

The expo is expected to witness over 1500 exhibitors, more than 40,000 visitors and representation from over 80 + Countries over the 3-days. It gives direct access highly targeted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration, and many more along with National and State Regulatory Boards, and Policymakers to congregate and conduct business, arrive at solution-driven innovations to counteract economic uncertainties and domestic trade in India.

Some of the key exhibitors include Hetero, Aurobindo, Signet, Teva, Optimus, Lonza Capsules, Merck, IMCD, Fette Compacting, Elmach, ACG, BD Pharma, IMA, Cadmach, GEA and many more. This year again the expo garnered extensive support from associations like Pharmexcil, CIPI, IDMA, ASPA, IPA, IPEC, and KDPMA reaffirming it as the industry’s most promising show.

Emphasizing this year’s CPhI and P-MEC India Expo, Yogesh Mudras, Managing Director, Informa Markets in India said, “The Indian pharma Market is rising at an annual growth rate of 15%, which is twice the world market growth rate. To further accelerate the growth of this industry, the government has approved incentives to the tune of almost INR 22,000 crores and 100% FDI, under the automatic route for greenfield pharmaceuticals.

“Over the last 15 years, our show CPhI and P-MEC India has demonstrated excellence in supporting the industry and growing along with it by curating highly effective platforms for showcasing technology solutions, knowledge sharing, networking, and advocacy in the past and will continue to act as a catalyst to ‘Make in India ‘movement and provide an impetus to Indian economy. The expo will surely provide a huge platform to establish and enhance business by meeting active suppliers looking for collaboration with the Indian Pharma and Healthcare market. Every edition of CPhI and P-MEC India has set a successful milestone for its esteemed visitors, and this year too, we will raise the bar to give a significant boost to this industry.”

Alongside the display of the latest technologies, of CPhI & P-MEC India, the India Pharma Week, which will include 9th Annual India pharma awards and CEO Roundtable on Day 1, will bring all key stakeholders in the pharmaceutical industry on a single platform to discuss, deliberate, and share their thoughts on achieving the next phase of growth in pharma. Day 2 will see the Women in Pharma Roundtable, which is an initiative aimed at acknowledging and celebrating the significant and continued contribution of women to the pharmaceutical industry in a closed-door roundtable discussion.